Abstract: The present invention relates to iridium complexes suitable for use in organic electroluminescent devices, especially as emitters.

Abstract: An organometallic compound is represented by Formula 1 and an organic light-emitting device includes the same. The organic light-emitting device includes: a first; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode and including an emission layer, wherein the organic layer includes an organometallic compound represented by Formula 1.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound having a formula (LA)mIr(LB)3?m having a structure selected from is disclosed. In the structures of formula (LA)mIr(LB)3-m, m is 1 or 2, R1, R2, R3, R4, and R5 are each independently selected from hydrogen, deuterium, C1 to C6 alkyl, C1 to C6 cycloalkyl, and partially or fully deuterated variants thereof, and partially or fully fluorinated variants thereof, and, R6 is selected from C1 to C6 alkyl, C1 to C6 cycloalkyl, and partially or fully deuterated variants thereof, and partially or fully fluorinated variants thereof.

Abstract: Provided is a compound of Chemical Formula 1: and to an organic light emitting device comprising the same.

Abstract: Dendrimer compositions and methods for the treatment of one or more inflammatory and/or angiogenic diseases and/or disorders of the eye include hydroxyl-terminated dendrimers complexed or conjugated with one or more active agents for the treatment or alleviation of one or more symptoms of the diseases of the eye, and/or for diagnosing the diseases and/or disorders of the eye. The dendrimers may include one or more ethylene diamine-core poly(amidoamine) (PAMAM) hydroxyl-terminated generation-4, 5, 6, 7, 8, 9, or 10 dendrimers. The active agents may be VEGFR tyrosine kinase inhibitors including sunitinib or analogues thereof. Preferably, the compositions are suitable for administration via a systemic route to target activated microglia/macrophages in retina/choroid.

Abstract: The present invention provides a thin-film forming raw material, which is used in an atomic layer deposition method, including a compound represented by the following general formula (1): where R1 to R4 each independently represent an alkyl group having 1 to 5 carbon atoms, and A1 represents an alkanediyl group having 1 to 5 carbon atoms.

Abstract: Disclosed is an organic light-emitting material including a 3-deuterium-substituted isoquinoline ligand. The organic light-emitting material is a metal complex including a 3-deuterium-substituted isoquinoline ligand and an acetylacetonate ligand, which can be used as a light-emitting material in a light-emitting layer of an organic electroluminescent device. These novel complexes can effectively prolong device lifetime. Further disclosed is an electroluminescent device including the metal complex and a compound formulation.

Abstract: A novel compound having a first ligand LA of is disclosed. The compound is useful as emitter dopant in OLEDs.

Abstract: Provided is a compound of Chemical Formula 1: wherein: among X1 to X4, one of X1 and X2, X2 and X3, or X3 and X4 are linked with * in the following Chemical Formula 2, and of the remaining two, one is hydrogen, and the other is R3: R1 and R2 are each independently hydrogen, deuterium, halogen, cyano, amino, a substituted or unsubstituted C1-60 alkyl, a substituted or unsubstituted C1-60 haloalkyl, a substituted or unsubstituted C1-60 alkoxy, a substituted or unsubstituted C1-60 haloalkoxy, a substituted or unsubstituted C3-60 cycloalkyl, a substituted or unsubstituted C2-60 alkenyl, a substituted or unsubstituted C6-60 aryl, a substituted or unsubstituted C6-60 aryloxy, or a substituted or unsubstituted C2-60 heterocyclic group containing one or more heteroatoms selected from the group consisting of N, O and S; one of R3 is hydrogen, and the other is —Si(R4)(R5)(R6), R4 to R6 are each independently hydrogen, deuterium, cyano, a substituted or unsubstituted C1-60 alkyl, a substituted or unsubst

Abstract: An organic electroluminescent device, which has a pair of electrodes and at least one organic layer including a luminescent layer between the pair of electrodes, wherein at least one layer between the pair of electrodes comprises at least one metal complex having a tridentate- or higher polydentate-chain structure ligand.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.

Abstract: Platinum compounds of Formulas I and II useful in a variety of devices, such as, for example organic-light emitting diodes (OLEDs).

Abstract: Tridentate platinum, palladium, and gold complexes of Formulas A-I and A-II and tridentate iridium and rhodium compounds of Formulas B-I, B-II, and B-III suitable for delayed fluorescent and phosphorescent or phosphorescent emitters in display and lighting applications.

Abstract: Novel Iridium complexes having three different bidentate ligands useful for phosphorescent emitters in OLEDs are disclosed. At least one of the three different bidentate ligands is a carbene ligand.

Abstract: Tetradentate platinum and palladium complexes based on biscarbazole and analogues for full color displays and lighting applications.

Abstract: The present invention refers to a process for transition-metal-assisted 18F-deoxyfluorination of phenols. The transformation benefits from readily available phenols as starting materials, tolerance of moisture and ambient atmosphere, large substrate scope, and translatability to generate doses appropriate for positron emission tomography (PET) imaging.

Abstract: The present invention provides a data transmitting circuit, a data receiving circuit and a data transferring apparatus. In one of the implementations of the data transmitting circuit, the first end of the primary coil of a transformer is connected to a first power supply interface, and the second end of the primary coil of the transformer is connected to the first end of a current limiting module and the first end of a first capacitor respectively; the first end of the secondary coil of the transformer is connected to a second power supply interface, and the second end of the secondary coil of the transformer is connected to a transmitting interface; the second end of the current limiting module and the second end of the first capacitor are both connected to the input end of a switch module.

Abstract: The present invention provides a method for producing a cyclometalated iridium complex, the method including producing a cyclometalated iridium complex by reacting a cyclometalated iridium complex raw material including an organoiridium compound with an aromatic heterocyclic bidentate ligand capable of forming an iridium-carbon bond and an iridium-nitrogen bond, and using as the raw material an organoiridium compound including a substructure represented by the following General Formula (1). The present invention is capable of producing a cyclometalated iridium complex with a high yield without by-production of a halogen-crosslinked iridium dimer. (in General Formula (1), Ir represents an iridium atom, and O represents an oxygen atom).

Abstract: Novel Pt tetradentate complexes having Pt—O bond is disclosed. These complexes are useful as emitters in phosphorescent OLEDs.

Abstract: Tridentate cyclometalated complexes with rigid six-membered coordination rings of General Formula I having tunable emission wavelengths in the visible range. These emitters are suitable for full color displays and lighting applications.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.

Abstract: A compound having the formula [LA]3-nIr[LB]n is disclosed. In the formula, LA is and LB is Formula I.

Abstract: A complex represented by Formula I: wherein: each Ar1, Ar2, Ar3, Ar4, and Ar5 present independently represents a substituted or unsubstituted aryl or heterocyclic aryl; each n is independently an integer of 0 to 4, as limited by valence; X represents O, S, NR1a, SiR1bR1c, or CR1dR1e, where each of R1a, R1b, R1c, R1d, and R1e independently represents substituted or unsubstituted C1-C4 alkyl; Y1a, Y2a, Y3b, and Y4a each independently represents N or C; Y3a represents N, CR2a, or SiR2b, where R2a and R2b represent hydrogen or substituted or unsubstituted C1-C4 alkyl, aryl, or heterocyclic aryl; Y5a and Y5b each independently represents C or N; and Y5c, Y5d, and Y5e each independently represents C, N, O, or S. Light emitting devices for full color displays may include a complex represented by Formula I.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.

Abstract: Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.

Abstract: An organometallic compound represented by Formula 1: M(L1)(L2)??Formula 1 wherein, in Formula 1, M, L1, and L2 are the same as described in the specification.

Abstract: Tridentate cyclometalated complexes with rigid six-membered coordination rings of General Formula I having tunable emission wavelengths in the visible range. These emitters are suitable for full color displays and lighting applications.

Abstract: Novel organic compounds comprising ligands with deuterium substitution are provided. In particular, the compound is an iridium complex comprising methyl-d3 substituted ligands. The compounds may be used in organic light emitting devices to provide devices having improved color, efficiency and lifetime.

Abstract: Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof.

Abstract: The present invention relates to novel bis-iridium-based Ir(III) complexes, labels manufactured using these complexes and a method for producing such complexes.

Abstract: A novel Pt tetradentate complexes having Pt—O bond is disclosed. These complexes are useful as emitters in phosphorescent OLEDs.

Abstract: An object is to provide a novel organometallic complex. Another object is to provide an organometallic complex that can exhibit yellow to blue phosphorescence. A platinum complex with a tetracoordinate ligand including a phenothiazine skeleton or a phenoxazine skeleton is provided. In the ligand, nitrogen at the 10-position and carbon at the 2-position of the phenothiazine skeleton or the phenoxazine skeleton have a pyridyl group and a phenoxy group, respectively. A five-membered heteroaromatic residue is present at the 3-position of the phenoxy group. The five-membered heteroaromatic residue has two or three nitrogen atoms in its skeleton. Carbon at the 1-position of the phenothiazine skeleton or the phenoxazine skeleton and carbon at the 2-position of the phenoxy group are bonded to platinum, and nitrogen of the pyridyl group and nitrogen or carbene carbon of the five-membered heteroaromatic residue are coordinated to platinum.

Abstract: A compound containing a partial structure of Formula I: is provided. In the structure of Formula I, M is a metal with an atomic number of at least 40; RA, RB, and RC are each independently 5 or 6 membered aryl or heteroaryl rings; R1, R2, R3, and A are each independently selected from a variety of substituents and combinations thereof; A is optionally bonded to RA or RC to form a fused ring; X1 is B, C, N, O, S or Se; X2-X7 are independently B, C or N; and Y1-Y2 are independently C or N. Formulations and devices, such as an OLEDs, that include the compound containing a structure of Formula I are also described.

Abstract: An organometallic compound represented by Formula 1: wherein in Formula 1, CY1, M, L, R1, R2, R3, R4, a1, a2, n1, and n2 are described in the specification.

Abstract: Tridentate cyclometalated complexes with rigid six-membered coordination rings of General Formula I having tunable emission wavelengths in the visible range. These emitters are suitable for full color displays and lighting applications.

Abstract: Platinum compounds of Formulas I and II useful in a variety of devices, such as, for example organic-light emitting diodes (OLEDs).

Abstract: Provided is a compound for an organic optoelectric device, an organic light emitting diode including the same, and a display device including the organic light emitting diode, wherein the compound for an organic optoelectric device is represented by Chemical Formula 1. The Chemical Formula 1 and description thereof are the same as described in the specification.

Abstract: The present invention relates to the use of aromatic boronic acid or borinic acid derivatives in organic electronic devices, in particular electroluminescent devices.

Abstract: Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof.

Abstract: Disclosed herein are an iridium complex having improved luminous efficiency and emission lifetime, a method for producing the same, an organic electroluminescent element using the iridium complex, and a display device and a lighting device that include the organic electroluminescent element. The iridium complex is contained in at least one organic layer sandwiched between an anode and a cathode of an organic electroluminescent element, and has a coefficient of external influence of 0.73 ?2/MW or less as defined by the following definition equation: Coefficient of external influence (Svdw)=Van der Waals surface area [?2]/molecular weight (MW).

Abstract: A ligand having the structure or its enantiomer; (I) wherein: each one of Ra, Rb, Rc and Rd is selected from alkyl, cycloalkyl, and aryl; the bridge group is selected from CH2NH; *CH(CH3)NH(C*,R); and the organocatalyst is an organic molecule catalyst covalently bound to the bridge group. Also, a catalyst having the structure or its enantiomer: (II) wherein: each one of Ra, Rb, Rc and Rd is selected from alkyl, cycloalkyl, and aryl; the bridge group is selected from CH2NH; *CH(CH3)NH(C*,R); and *CH(CH3)NH(C*,S); the organocatalyst is an organic molecule catalyst covalently bound to the bridge group; and M is selected from the group consisting of Rh, Pd, Cu, Ru, Ir, Ag, Au, Zn, Ni, Co, and Fe.

Abstract: The invention relates to C—H activated olefin metathesis catalyst compounds, the preparation of such compounds, and the use of such catalysts in the metathesis of olefins and olefin compounds, more particularly, the use of such catalysts in Z selective olefin metathesis reactions. In general, the catalyst compounds of the invention comprise a Group 8 metal (M), an alkylidene moiety (?CR1R2), or more generally (?(C)mCR1R2), an anionic ligand (X1), two or three neutral ligands (L1, L2, and L3) and a 2-electron anionic donor bridging moiety (Q*) that forms a chelate ring structure in conjunction with L1 and M.

Abstract: The metal complex comprises a multivalent carboxylic acid compound, at least one metal ion selected from ions of metals belonging to Groups 2 to 13 of the periodic table, an organic ligand capable of multidentate binding to the metal ion, and a C1 or C2 monocarboxylic acid compound. The metal complex has excellent gas adsorption, storage, and separation performance as well as excellent durability. The metal complex is stably present under high temperature and high humidity, and can maintain high adsorption performance.

Abstract: The present invention is concerned with a staining dye for staining a biological cell, comprising dye molecules with a positively charged polar head group for attraction to cell membrane of the cell and for refraining the dye molecules from entering the cytoplasm, and one or more hydrophobic groups for interaction with phospholipids of the cell membrane. The dye molecules are phosphorescent transition metal polypyridine complexes having a metal center and ligands which are non-organic fluorophores.

Abstract: Described herein are nickel pre-catalysts and related compositions and methods. The nickel pre-catalysts may be activated to form catalysts which may be utilized in organic reactions.

Abstract: A dye sensitized solar cell, wherein a compacting compound whose molecular structure comprises a terminal group, a hydrophobic part and an anchoring group is co-adsorbed together with the dye on the semi-conductive metal oxide layer of the photoanode, forming a dense mixed self-assembled monolayer.

Abstract: The present invention provides a novel ruthenium complex which has an excellent catalytic activity in terms of reactivity for an asymmetric reduction of a carbonyl compound and enantioselectivity, a catalyst using the ruthenium complex, and a method for preparing optically active alcohol compounds using the ruthenium complex. The present invention relates to a ruthenium complex having a ruthenacycle structure, a catalyst for an asymmetric reduction consisting of the ruthenium complex, and a method for preparing optically active alcohol compounds using the ruthenium complex.

Abstract: Organic devices comprising an organic layer, wherein the organic layer is non-electroluminescent and comprises a cross-linked metal complex. The cross-linked metal complex may be formed by cross-linking a cross-linkable iridium complex, which comprises a set of ligands coordinated to a central iridium atom. One or more of the ligands have attached thereon, one or more polymerizable groups that are able to polymerize with other molecules to form intermolecular covalent bonds. In some cases, the organic layer may also comprise a dopant. Also provided are a method of making an organic light-emitting device, an iridium complex, and an organic-light emitting device using certain iridium complexes.